Sell, succeed, or continue
A dental practice is an economic asset and a relationship among patients, team, owner, community, records, systems, and clinical judgment. DenQAI helps a seller compare the complete after-tax economics while making stewardship, authority, restrictions, and post-close obligations visible.
Founder account · not prevalence evidence
Four of six near-retirement dentists I worked with more than 25 years ago had received their practices from unrelated predecessors. They said the reason was the patients and families.
This firsthand history does not show how common gifted practices were. It preserves a different conception of value: the retiring dentist was transferring a clinical trust, not merely monetizing a three-year financial photograph.
Modern sellers still need retirement security and fair value. The work is to keep price from becoming the only instruction given to a broker, adviser, or buyer.
Seven credible paths
Each path has different timing, financing, tax, governance, patient, employment, and failure mechanics. A path becomes real only when its supporting documents and conditions to pause, renegotiate, or walk away are written.
Test whether a right-sized operating redesign, manager depth, fewer clinical days, or a defined later transition can meet retirement and patient needs.
Owner workload, sustainable cash, capital needs, household plan, and a dated future succession route
Transfer philosophy, patient trust, team knowledge, and authority over time before the full purchase becomes irreversible.
Employment, decision rights, milestones, financing, price method, default, failure, and exit
Sell defined interests or economics in steps while both parties test clinical fit, operating capability, governance, and financing.
Ownership law, voting, distributions, deadlock, later pricing, guarantees, restrictions, and unwind
Compare a qualified individual buyer on the same cash, tax, timing, patient, team, control, and certainty basis as an institutional buyer.
Buyer identity, financing, transferable cash, lease, team, patient handoff, and closing evidence
Use price structure to expand private-buyer access only after credit, collateral, priority, servicing, tax, and default risks are independently reviewed.
Note, amortization, security, lender consent, covenants, remedies, guarantees, and collection risk
Combine with another locally owned practice when the clinical model, capacity, records, team, real estate, governance, and community plan can actually integrate.
Entity and control map, service lines, patient access, staffing, payer, facilities, governance, and separation terms
Normalize cash, holdbacks, earnouts, rollover equity, employment, management services, restrictions, control, and exit across the entire post-close period.
Purchase, employment, management, equity, governance, service, fee, restriction, data, and liquidity documents
DSO and group-offer normalization
The label may combine cash, debt assumptions, contingent proceeds, retained equity, compensation for future labor, or value that depends on systems the seller no longer controls.
Cash at closing less debt payoff, transaction costs, and independently estimated closing tax.
Seller notes and holdbacks remain outside cash at close and carry timing, collection, offset, and dispute risk.
Earnouts are probability-weighted and may be entered at zero. Measurement authority and operating control matter.
Face value is not cash. Governance, dilution, senior claims, financial reporting, transfer limits, and an actual liquidity route determine realizability.
Post-close clinical compensation pays for labor. It is never represented as sale proceeds.
Employment, guarantees, indemnity, real estate, transition, name use, restrictions, and patient obligations survive the closing event.
DenQAI permits a zero realization probability and never adds rollover equity’s face value to cash at closing. The seller supplies the scenario; independent advisers verify the documents, tax, valuation, and legal consequences.
Clinical authority
A document can say the dentist controls clinical decisions while staffing, appointment templates, payer participation, supply budgets, laboratory limits, capital approvals, data access, compensation, or termination rights shape what is practical.
Who has the written right to decide, approve, veto, modify, or terminate?
Who controls the resources, systems, budget, staffing, schedule, data, and consequences around the decision?
Which purchase, employment, management, policy, equity, or operating record controls—and what can change unilaterally?
What happens when the dentist disagrees, is terminated, becomes disabled, misses a target, or wants to leave?
Map diagnosis, appointment time, staffing, materials, laboratories, referrals, payer participation, records, quality, capital, and clinician employment separately.
Patient stewardship
Discuss patient introductions, open treatment, remakes, records, communication, emergency coverage, vulnerable patients, team continuity, payer changes, seller name use, later control changes, and the beginning and end of the handoff.
Set buyer-type, private-buyer exposure, confidentiality, data, patient, team, price, and offer-presentation instructions.
Normalize every proposal and identify the documents, authority, contingencies, restrictions, and obligations that can change value.
Assign open cases, records, communication, staff process, payer continuity, emergency care, introductions, and the seller’s defined transition role.
Track earnout, holdback, equity, employment, guarantees, real estate, restrictions, name use, patient obligations, disputes, and exit milestones.
It does not make every expectation legally enforceable. It prevents the parties from discovering after closing that “patient-centered” meant something different to each of them.
Broker and adviser control
Document the client, duties, compensation base, payment trigger, separate sourcing or referral benefits, buyer access, offer log, marketing scope, ownership, data flow, and post-engagement deletion. A connection must be proved at the level actually claimed.
Do not infer that all qualified individual buyers saw the opportunity or that a higher headline produced a higher after-tax outcome.
Current DenQAI boundary
DenQAI does not list a practice, contact a buyer, receive patient or employee data, upload deal documents, value a business, negotiate terms, determine tax, give legal advice, certify fairness, or approve a closing.
The workbench compares entered paths without recommending a buyer or producing a hidden score.
Use coded aggregate values and short neutral summaries. Keep contracts and sensitive records with authorized advisers.
Market access or advertised DSO services do not prove compensation, ownership, steering, or data sharing.
An independent succession marketplace requires identity, authorization, privacy, professional-ownership, governance, security, and operating controls before launch.
Complete the ownership lifecycle
Begin with the seller mandate, then normalize the paths before signing exclusivity, a letter of intent, or an employment term sheet.
Open the succession workbench